Kiora Pharmaceuticals (KPRX) Metrics: History & Chart

Kiora Pharmaceuticals, Inc.(KPRX)

Biotechnology · Encinitas, CA

$2.55+0.02 (+0.79%)

Delayed quote: Oct 6, 2026, 10:57 AM EDT

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently in Phase 2 trials for addressing the ocular manifestations of rheumatoid arthritis, as well as non-infectious posterior uveitis. Furthermore, Kiora is advancing KIO-201, another eye drop, which is in Phase 3 clinical trials, designed to facilitate corneal wound healing following PRK surgery. Established in 1998, the company adopted its current name in November 2021, having previously operated as Eyegate Pharmaceuticals, Inc. Kiora Pharmaceuticals maintains its corporate headquarters in Salt Lake City, Utah.

Encinitas, CA

13 employees

www.kiorapharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Brian Strem

View full financials

Third-Party DCF Estimate (FMP)	$2.55
Price Gap vs Third-Party Estimate	+0.72%

7D Total Return	-5.24%
30D Total Return	-0.78%
YTD Total Return	+28.44%
1Y Total Return	-8.00%
3Y Total Return	-53.84%
5Y Total Return	-99.61%
10Y Total Return	-99.97%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+28.44%
2025	-40.30%
2024	-29.79%
2023	-84.78%
2022	-94.32%
2021	-69.37%
2020

CAGR TTM	-7.96%
CAGR 3Y	-22.71%
CAGR 5Y	-67.06%
CAGR 10Y	-55.97%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	4.58
PE Ratio Avg TTM	2.28
PE Ratio Avg 3Y	2.28
Current VS TTM Avg	+100.93%
Current VS 3Y Avg	+100.93%
Current VS 5Y Avg	+100.93%

All Metrics

KPRX Valuation Metrics

KPRX Stock Price Metrics

KPRX Dividend Metrics

KPRX Growth Rate Metrics

KPRX Discounted Cash Flow Metrics

KPRX Returns By Period

KPRX Yearly Returns

KPRX Average Annual Returns By Period (CAGR)

KPRX Revenue Metrics

KPRX PE Ratio Metrics

KPRX PS Ratio Metrics

KPRX PB Ratio Metrics

KPRX Price to Free Cash Flow Ratio Metrics

KPRX Debt to Equity Ratio Metrics

KPRX PEG Ratio Metrics

KPRX FCF Yield

KPRX Earnings Yield

KPRX EBITDA Yield

KPRX OCF Yield

KPRX EV/EBIT Ratio Metrics

KPRX EV/EBITDA Ratio Metrics

KPRX EV/Assets Ratio Metrics

KPRX EV/Sales Ratio Metrics

KPRX Current Ratio Metrics

KPRX Quick Ratio Metrics

KPRX ROIC Metrics

KPRX Return on Assets Metrics

KPRX Return on Equity Metrics

KPRX Net Profit Margin Metrics

KPRX Gross Profit Margin Metrics

KPRX Tax Rate Metrics

PS Ratio	0.61
PS Ratio Avg TTM	0.88
PS Ratio Avg 3Y	0.88
Current VS TTM Avg	-30.93%
Current VS 3Y Avg	-30.93%
Current VS 5Y Avg	-99.99%

PB Ratio	0.93
PB Ratio Avg TTM	0.61
PB Ratio Avg 3Y	0.57
Current VS TTM Avg	+51.60%
Current VS 3Y Avg	+62.07%
Current VS 5Y Avg	-57.50%

PFCF Ratio	1.15
PFCF Ratio Avg TTM	2.12
PFCF Ratio Avg 3Y	2.12
Current VS TTM Avg	-45.80%
Current VS 3Y Avg	-45.80%
Current VS 5Y Avg	-45.80%

Debt/Equity Ratio	0.02
Debt/Equity Ratio Avg TTM	0.02
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	-7.58%
Current VS 3Y Avg	+75.80%
Current VS 5Y Avg	+55.22%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	86.78%
FCF Yield Avg TTM	40.57%
FCF Yield Avg 3Y	40.57%
Current VS TTM Avg	+113.89%
Current VS 3Y Avg	+113.89%
Current VS 5Y Avg	+113.89%

Earnings Yield	21.85%
Earnings Yield Avg TTM	44.71%
Earnings Yield Avg 3Y	44.71%
Current VS TTM Avg	-51.13%
Current VS 3Y Avg	-51.13%
Current VS 5Y Avg	-51.13%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	1.33
Ev/Ebit Ratio Avg TTM	2.09
Ev/Ebit Ratio Avg 3Y	2.09
Current VS TTM Avg	-36.51%
Current VS 3Y Avg	-36.51%
Current VS 5Y Avg	-36.51%

Ev/Ebitda Ratio	1.33
Ev/Ebitda Ratio Avg TTM	2.08
Ev/Ebitda Ratio Avg 3Y	2.08
Current VS TTM Avg	-36.06%
Current VS 3Y Avg	-36.06%
Current VS 5Y Avg	-36.06%

Ev/Assets Ratio	0.37
Ev/Assets Ratio Avg TTM	0.17
Ev/Assets Ratio Avg 3Y	0.79
Current VS TTM Avg	+120.39%
Current VS 3Y Avg	-53.03%
Current VS 5Y Avg	-65.74%

Ev/Sales Ratio	0.38
Ev/Sales Ratio Avg TTM	0.51
Ev/Sales Ratio Avg 3Y	0.51
Current VS TTM Avg	-25.36%
Current VS 3Y Avg	-25.36%
Current VS 5Y Avg	-99.99%

Current Ratio	8.97
Current Ratio Avg TTM	7.64
Current Ratio Avg 3Y	6.21
Current VS TTM Avg	+17.42%
Current VS 3Y Avg	+44.53%
Current VS 5Y Avg	+80.76%

Quick Ratio	8.97
Quick Ratio Avg TTM	7.64
Quick Ratio Avg 3Y	6.21
Current VS TTM Avg	+17.42%
Current VS 3Y Avg	+44.53%
Current VS 5Y Avg	+80.76%

ROIC	(59.42%)
ROIC Avg 3Y	(39.87%)
ROIC Avg 5Y	(50.48%)
Current VS 3Y Avg	-49.02%
Current VS 5Y Avg	-17.70%
Current VS 10Y Avg	+7.26%

ROA	(46.21%)
ROA Avg TTM	(10.73%)
ROA Avg 3Y	(8.88%)
Current VS TTM Avg	-330.65%
Current VS 3Y Avg	-420.37%
Current VS 5Y Avg	-288.81%

ROE	(65.18%)
ROE Avg TTM	(60.80%)
ROE Avg 3Y	(58.11%)
Current VS TTM Avg	-7.20%
Current VS 3Y Avg	-12.16%
Current VS 5Y Avg	+17.97%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A